Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lagos COVID-19 Chloroquine Treatment Trial
PACTR202004801273802Phase 3Unknown
- Sponsor
- Lagos State Government
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Chloroquine phosphate, Hydroxychloroquine sulphate and Lopinavir + ritonavir (3 arms). Primary endpoint: Status on 7-point ordinal scale. Status: unknown.
02
Drugs
chloroquinehydroxychloroquinelopinavir + ritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202004801273802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202004801273802.